Suppr超能文献

[新型抗真菌药物治疗非侵袭性肺曲霉病]

[Treatment of non-invasive pulmonary aspergillosis with new anti-fungal drugs].

作者信息

Kurashima Atsuyuki

机构信息

Division of Clinical Research, National Hospital Organization Tokyo National Hospital, 3-1-1, Takeoka, Kiyose-shi, Tokyo 204-8585, Japan.

出版信息

Kekkaku. 2007 Feb;82(2):143-7.

Abstract

Pulmonary aspergilloma is characterized radiographically by the presence of a fungal ball. However, this disease proscess begins from a considerably earlier date. X-ray findings can detect the early stages of this disease better than any other inspective methods. From the treatment perspective, it is too late to start anti-fungal drugs after a fungus ball has already appeared. Therefore, image analysis of this disease process is important for early diagnosis. We examined 48 lesions in 41 cases where images were traceable before the recovery of precedent lung diseases. We could divide the development of pulmonary aspergillosis into the following 10 steps, through analysis of all films including CT findings. Step 0: Basic state Step 1: Initial consolidation Step 2: Cavity wall thickening Step 3: Further thickening Step 4: Irregular inner layer Step 5: Desquamation Step 6: Fungus ball formation Step 7: Enlargement downward Step 8: Spreading to other lung field Step 9: Extra pulmonary extension The sequential line could be indicated as the development of pulmonary aspergillosis through plotting the points of each steps and elapsed days from step 0. The longest observation days are about 8200 days. We learned the followings from this analysis. 1. The courses of progression revealed that pulmonary aspergillosis is not worsening linearly, while with ups and downs. 2. General tendencies are divided into two groups as a rapid development group and as a chronic development group. 3. Fungus ball is configured on average one month later after the irregular inner layer appeared. 4. Initial consolidation appears on average at 783 days after the image of the precedent disease improved it most, and fungus ball is configured afterwards at 1588 days. 5. Pulmonary aspergillosis is not a static disease that has dynamic process. 6. Spontaneous limited remissions were observed in 14%, but the usage of anti-fungal drugs (mainly with ITCZ) shortened the interval period to remission significantly. 7. In the same analysis of another 21 cases with MCFG treatment, the interval period to remission was 66.4 days, and 17 cases with VRCZ treatment , that was 58.5 days. Consequently, pulmonary aspergilloma originates from minor changes without fungus ball, and terminates with fatal extensive destructive lesions. This disease is configured with each different sequential stage. The clinical terms of "Pulmonary aspergilloma" or "Semi Invasive Pulmonary Aspergillosis" describes only a limited phase of this chronic and prolonged disease. We consider that the term of "Chronic Necrotizing Pulmonary Aspergillosis" is more suitable expression for this disease entity, if the original definition could be re-defined.

摘要

肺曲菌球在影像学上的特征是存在真菌球。然而,这种疾病过程从相当早的时候就开始了。X线检查结果比任何其他检查方法都能更好地检测出这种疾病的早期阶段。从治疗角度来看,在真菌球已经出现后再开始使用抗真菌药物就太晚了。因此,对这种疾病过程进行图像分析对于早期诊断很重要。我们检查了41例患者的48个病灶,这些患者在先前肺部疾病恢复之前图像可追溯。通过分析包括CT检查结果在内的所有影像,我们可以将肺曲霉菌病的发展分为以下10个阶段。阶段0:基础状态;阶段1:初始实变;阶段2:空洞壁增厚;阶段3:进一步增厚;阶段4:不规则内层;阶段5:脱屑;阶段6:真菌球形成;阶段7:向下扩大;阶段8:扩散到其他肺野;阶段9:肺外扩展。通过绘制每个阶段的点以及从阶段0开始经过的天数,可以将这条连续线表示为肺曲霉菌病的发展过程。最长观察天数约为8200天。我们从该分析中得到以下结论。1. 进展过程显示,肺曲霉菌病并非呈线性恶化,而是有起伏。2. 总体趋势分为快速发展组和慢性发展组两组。3. 真菌球平均在不规则内层出现一个月后形成。4. 初始实变平均出现在先前疾病影像改善最明显后的783天,之后真菌球在1588天形成。5. 肺曲霉菌病不是一种静态疾病,而是有动态过程。6. 观察到14%的患者有自发的局限性缓解,但使用抗真菌药物(主要是伊曲康唑)显著缩短了缓解间隔期。7. 在对另外21例接受MCFG治疗的病例进行的相同分析中,缓解间隔期为66.4天,对17例接受伏立康唑治疗的病例,缓解间隔期为58.5天。因此,肺曲菌球起源于无真菌球的微小变化,并以致命的广泛破坏性病变告终。这种疾病由各个不同的连续阶段构成。“肺曲菌球”或“半侵袭性肺曲霉菌病”这些临床术语仅描述了这种慢性和病程较长疾病的有限阶段。我们认为,如果能重新定义原始定义,“慢性坏死性肺曲霉菌病”这个术语更适合用于描述这种疾病实体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验